Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Equity

v3.25.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Additional Paid-in  Capital
Distributions in Excess of Accumulated Earnings
Accumulated Other Comprehensive Income
Non- Controlling Interests
Series B Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Series C Preferred Stock
Preferred Stock
Series E Preferred Stock
Series E Preferred Stock
Total Stockholders’ Equity
Series E Preferred Stock
Preferred Stock
Series E Preferred Stock
Additional Paid-in  Capital
Beginning balance, preferred stock (in shares) at Dec. 31, 2023                 5,956,065   10,156,509     235,841  
Beginning balance at Dec. 31, 2023 $ 719,613 $ 719,613 $ 36 $ 856,206 $ (144,011) $ 7,366 $ 0   $ 6   $ 10     $ 0  
Beginning balance, common stock (in shares) at Dec. 31, 2023     35,838,442                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of Series E Preferred Stock, net (in shares)                           11,340  
Issuance of Series E Preferred Stock, net                       $ 249 $ 249   $ 249
Redemptions of Series E Preferred Stock, net (in shares)                           0  
Net income 13,567 13,567     13,567                    
Dividends—cumulative redeemable preferred stock (6,118) (6,118)     (6,118)                    
Distributions—OP Units and common stock (5,000) (5,000)     (5,000)                    
Comprehensive income (loss) attributable to the Company 1,008 1,008       1,008                  
Ending balance, preferred stock (in shares) at Mar. 31, 2024                 5,956,065   10,156,509     247,181  
Ending balance at Mar. 31, 2024 723,319 723,319 $ 36 856,455 (141,562) 8,374 0   $ 6   $ 10     $ 0  
Ending balance, common stock (in shares) at Mar. 31, 2024     35,838,442                        
Beginning balance, preferred stock (in shares) at Dec. 31, 2024               5,840,889 5,840,889 9,954,863 9,954,863 252,436   252,436  
Beginning balance at Dec. 31, 2024 $ 687,182 687,182 $ 36 854,059 (174,561) 7,632 0   $ 6   $ 10     $ 0  
Beginning balance, common stock (in shares) at Dec. 31, 2024 36,184,658   36,184,658                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of Series E Preferred Stock, net                       $ (4) (4)   (4)
Redemptions of Series E Preferred Stock, net (in shares)                           (800)  
Redemptions of Series E Preferred Stock, net                       $ (18) $ (18) $ (18) $ (18)
Net income $ 15,108 15,108     15,108                    
Dividends—cumulative redeemable preferred stock (6,002) (6,002)     (6,002)                    
Distributions—OP Units and common stock (5,070) (5,070)     (5,070)                    
Comprehensive income (loss) attributable to the Company (1,318) (1,318)       (1,318)                  
Ending balance, preferred stock (in shares) at Mar. 31, 2025               5,840,889 5,840,889 9,954,863 9,954,863 251,636   251,636  
Ending balance at Mar. 31, 2025 $ 689,878 $ 689,878 $ 36 $ 854,037 $ (170,525) $ 6,314 $ 0   $ 6   $ 10     $ 0  
Ending balance, common stock (in shares) at Mar. 31, 2025 36,184,658   36,184,658